ALNYLAM PHARMACEUTICALS, INC.
Pharmaceutical Preparations | SIC: 2834Phone: (617) 551-8200
EIN: 770602661
State Location: MA
- Nasdaq:ALNY
Form: 8-K
Filing Date: 30 Apr 2026Report Date: 30 Apr 2026
Accepted: 30 Apr 2026 06:04 a.m.
Accession Number: 0001628280-26-028601
File Number: 001-36407
Film Number: 26920191
Items: 2.02,9.01
Documents
Primary Document: 8-K
Accepted: 30 Apr 2026 06:04 a.m.
0001628280-26-028601-index-headers.html
Last Modified: 30 Apr 2026 06:04 a.m.
0001628280-26-028601-index.html
Last Modified: 30 Apr 2026 06:04 a.m.
0001628280-26-028601.txt
Last Modified: 30 Apr 2026 06:04 a.m.
0001628280-26-028601-xbrl.zip
Last Modified: 30 Apr 2026 06:04 a.m.
alny-20260430.xsd
Last Modified: 30 Apr 2026 06:04 a.m.
alny-20260430_htm.xml
Last Modified: 30 Apr 2026 06:04 a.m.
alny-20260430_lab.xml
Last Modified: 30 Apr 2026 06:04 a.m.
alny-20260430_pre.xml
Last Modified: 30 Apr 2026 06:04 a.m.
alny2026q1earningsrelease.htm
Last Modified: 30 Apr 2026 06:04 a.m.
FilingSummary.xml
Last Modified: 30 Apr 2026 06:04 a.m.
logoforera.jpg
Last Modified: 30 Apr 2026 06:04 a.m.
MetaLinks.json
Last Modified: 30 Apr 2026 06:04 a.m.
R1.htm
Last Modified: 30 Apr 2026 06:04 a.m.
report.css
Last Modified: 30 Apr 2026 06:04 a.m.
Show.js
Last Modified: 30 Apr 2026 06:04 a.m.